On March 16, 2026, the Board of Directors of Tipharco Pharmaceutical Joint Stock Company (DTG) issued Resolution No. 08/2026/NQ-HĐQT-DTG regarding the approval of the List of Candidates for the Board of Directors and the Supervisory Board for the 2026–2031 term; the approval of the extension for the nomination and candidacy period for members of the Supervisory Board for the 2026–2031 term until 16:00 on March 17, 2026, at the request of a major shareholder; and the approval of adjustments and updates to the documents related to the 2026 Annual General Meeting of Shareholders. Document details are as follows:

• Proposal No. 12.1/2026/TTĐH-HĐQT-DTG dated March 16, 2026 regarding the approval of the mechanism for supplementary nomination of Board of Directors members and the List of expected candidates for the 2026–2031 term introduced by the Board of Directors for supplementary nomination under the mechanism in case of approval by the General Meeting of Shareholders.
• List of Candidates for the Board of Directors (2026–2031 term)
• List of Candidates for the Supervisory Board (2026–2031 term)
• 2026 AGM Agenda
• 2026 AGM Voting Ballot Form
• Election Ballot Form for the Board of Directors (2026–2031 term)
• Election Ballot Form for the Supervisory Board (2026–2031 term)
• Draft Resolution of the 2026 Annual General Meeting of Shareholders
• Curriculum Vitae (CV) of candidates